Form 8-K - Current report:
SEC Accession No. 0001493152-24-051209
Filing Date
2024-12-23
Accepted
2024-12-23 08:00:16
Documents
18
Period of Report
2024-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58979
2 ex10-1.htm EX-10.1 307848
3 ex10-2.htm EX-10.2 159026
4 ex10-3.htm EX-10.3 108394
5 ex99-1.htm EX-99.1 15827
6 ex99-1_001.jpg GRAPHIC 16549
  Complete submission text file 0001493152-24-051209.txt   976029

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE fblg-20241220.xsd EX-101.SCH 3033
8 XBRL LABEL FILE fblg-20241220_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE fblg-20241220_pre.xml EX-101.PRE 24177
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3810
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 241569906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)